The CervicalStim™​​​ device is the only bone growth stimulation therapy approved by the FDA as a noninvasive, adjunctive treatment option for cervical fusion in patients at high-risk for non-fusion. The device uses a pulsed electromagnetic field (PEMF) to induce a low-level electrical field at the fusion site which stimulates bone healing at a molecular, cellular, and tissue level. With an overall clinical success rate of ​84 percent, the CervicalStim device increases fusion success significantly​ by 22 percent​ when used adjunctively to surgery.